Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
https://finance.yahoo.com/news/findit-features-members-hip-hop-142000390.html
Findit Features Members Hip Hop Bling, ClassWorx and Urban CBD Collective
Wed, December 2, 2020, 9:20 AM EST
ATLANTA, GA / ACCESSWIRE / December 2, 2020 / Findit, Inc. (OTC PINK:FDIT) owner of Findit.com, a full-service social networking platform which provides online marketing campaigns and tools for members to increase brand awareness through content creation and sharing, resulting in indexing in search engines is highlighting: Hip Hop Bling, ClassWorx and Urban CBD Collective.
Our first featured member is Hip Hop Bling. Hip Hop Bling has extended their Cyber Monday Sale making now the perfect time to stock up on all of your favorite iced out pieces and accessories. With Promo Code 'F25' you can up to 25% off your purchase! Just be sure to apply the promo code during checkout to get your discount. Hip Hop Bling sells high quality, fashion hip hop jewelry, including bracelets, chains, diamonds, watches, and more. Their jewelry offers an authentic look and feel to real diamond and gold jewelry but is offered at a more competitive price point. Hip Hop Bling is the trusted source for premium jewelry offered at incredible value, and their entire collection is available online at Hiphopbling.com. Hip Hop Bling has just launched their newest app, so you can grab all of your favorite hip hop jewelry on the go, available for Android and IOS devices.
Silo Pharma Announces Plans for a Phase 2B Investigator Lead Study Using Psychedelics Psilocybin and Lysergic Acid Diethylamide ("LSD") to Treat Parkinson’s Disease
https://finance.yahoo.com/news/silo-pharma-announces-plans-phase-133000255.html
Wednesdays New Blockbuster Biotech Stock (SILO) Poised to Breakout!
Wall Street Elites and Silicon Valley Are Investing Heavy Into This Space!
Dear Fellow Trader,
What if you could buy shares of Pfizer when it was a tiny, little-known company?
If you bought and held this biotech stock, even if all you bought is a few thousand bucks, you would be a multi-millionaire right now.
I’ve identified the next early-stage biopharmaceutical stock that could potentially ride the next biotech breakout wave.
Immediately turn your attention to Silo Pharma Inc. (SILO)
Silo Pharma Inc. is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research to innovatively address underserved conditions including Fibromyalgia, PTSD, Parkinson’s, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.
Wall Street & Silicon Valley Leaders Are Rushing
to Support Psychedelic Medicine
As psilocybin boldly merges into modern pharmacopeia, the emerging field of psychedelic medicine continues forward amidst this electrifying renaissance. Pioneers such as MAPS, Usona Institute and Compass Pathways have been awarded the coveted “breakthrough status” for their psilocybin-based therapies by the US Food & Drug Administration. This designation marked a historic moment for the overall psychedelic revolution and has caught the attention of various notable investors from Wall Street and Silicon Valley.
Peter Thiel, the notable billionaire backer of Compass Pathways, is the co-founder of PayPal and one of Facebook’s first major investors. He is also the chairman of aforementioned Palantir Technologies, which posted its best week since it went public in September, adding about $17BIL in market value as a broad rally in tech stocks helped fuel gains in the software maker.
Currently, Palantir is one of the tech industry’s most valuable private companies with a whopping valuation of $20BIL. Thiel’s combined investments in Palantir and Compass Pathways highlights the significant shift in attention towards psychedelics from big players in Wall Street and Silicon Valley.
Looking at Thiel’s track record along with the significant attention towards psychedelics from big players in Wall Street and Silicon Valley, Thiel may be onto something by investing in the psilocybin sector!
Introducing... SILO!
Now Turn Your Complete Attention to SILO
Wednesday's Focus Stock...
For investors of Silo Pharma, Inc. (SILO), a early-stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, and general supporters of the psilocybin and ‘magic mushroom’ market, the passage of a ballot measure in Oregon just a few weeks ago to allow licensed providers to administer the hallucinogenic substance found in magic mushrooms is a significant development. As some may recall, Oregon was the first state to decriminalize the possession of small amounts of cannabis, and among the first to authorize its use for medical purposes.
Pioneering Oregon then proved a safe and regulated commercial market for cannabis and state after state continues to follow. It is worth noting that Washington D.C. passed a similar measure for mushroom based psychedelics.
And what is also of interest is that as these seminal legislative changes occur, Silo Pharma seeks to develop its own standing in the markets, having recently announced its transition from the OTC Pink Market to the OTCQB® Venture Market.
It’s a significant move through the transparency required of OTCQB companies, being quoted on a more senior quotation medium, and introducing the Company to a possible greater pool of retail investors and institutions.
Psilocybin is in its infancy, and Silo Pharma appears to be in a nascent phase of its business plan despite a partnership with a major university already in place. As these new markets open up in Oregon and D.C., Silo is preparing to meet the moment.
Catalyst #1 Bullish Catalyst – Silo Pharma Announces Blockbuster Patent News of Three U.S. Provisional Patent Applications.
Silo Pharma, Inc. Announces Filing of Three
U.S. Provisional Patent Applications
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced the filing of three distinct U.S. Provisional Patent applications with the U.S. Patent and Trademark Office ("USPTO") pertaining to the central nervous system delivery of unique anti-inflammatory therapeutics coupled with psilocybin.
“Each of these provisional patents relates to the continued research and development of the central nervous system-homing peptides covered by the UMD option agreement to deliver certain compounds,” stated Eric Weisblum, Chairman and CEO of Silo Pharma.” We are excited to have taken this important action with respect to our recently announced collaboration with UMD.”
A provisional patent application is a critical step on the road to commercial viability. As the climate for intellectual property rights becomes more and more competitive, a provisional patent application successfully establishes an early effective filing date and allows the patent applicant or a licensee to ascribe the phrase "patent pending" to any product development and methodologies associated with the patent’s subject matter.
“These patent applications, together with Silo’s efforts to bring scientific talent, resources, and industry leaders together, allows the Company to continue its development of novel therapeutics in the psychedelic category,” stated Mr. Weisblum.
Catalyst #2 Bullish Catalyst – Another bullish catalyst is SILO Launches Scientific Advisory Board with Appointment of a Physician of John Hopkins University.
“Psilocybin research is one of the most intriguing and fastest growing areas of biotechnology, as it is believed that psychedelics hold the potential to address some of the largest and most challenging diseases such as depression, CNS related disorders, anxiety, PTSD, and Parkinson’s,” said Eric Weisblum, CEO of Silo Pharma. “The establishment of our Scientific Advisory Board reflects our commitment to pursuing multiple, strategic opportunities for privately-funded research. An advisory board of expert researchers will be instrumental in guiding us through the process of selecting and funding the best opportunities for the advancement of our mission and to maximize returns.”
Catalyst #3 Bullish Catalyst – Another bullish catalyst is Silo Pharma announced
Blockbuster News they're to explore unique peptide delivery of psilocybin utilizing this novel technology represents key differentiator in emerging psilocybin space.
Silo Pharma announced that it has executed an option agreement with the University of Maryland, Baltimore with respect to the exploration of the potential use of central nervous system-homing peptides in vivo and their use for the investigation and treatment of multiple sclerosis and other neuroinflammatory pathology. Silo Pharma’s intends to explore the development of unique therapeutics that utilize these CNS Homing Peptides. Silo plans on initiating studies to evaluate the potential use of this invention to deliver Psilocybin based therapeutics directly to targeted areas of a patient.
This technology refers to phage-encoded peptides identified as being unique, inflamed CNS-specific markers. These peptides zero in on the spinal cord and, to a lesser extent, the cerebellum, in a rodent model of Multiple Sclerosis (MS).
These peptides are designed to address many challenges, as they are expected to be pathology-specific (damaged, inflamed tissue only), are tissue specific (CNS), and can be used as an imaging tool for inflammation of the spinal cord. As such, Silo Pharma believes that they may be used in the detection of diseased tissue and for targeting therapeutic agents to the CNS to treat MS and other neuroinflammatory diseases.
“The option agreement gives Silo access to a potential unique and vital approach which significantly differentiates us within the Psilocybin space,” stated Eric Weisblum Chairman and CEO of Silo Pharma. “The ability to deliver psilocybin and other psychedelic compounds directly to targeted areas of the body with this technology could be significant by increasing the efficacy of the treatment while reducing the amount of medicine needed. There is a tremendous need for creative and unique therapeutics for patients suffering from rare diseases. We believe this novel approach coupled with our planned research of psilocybin as a therapeutic presents an exciting time for the company.”
As you can see, there are multiple bullish catalysts signaling breakout gain potential!
It’s important to remember that historically small-cap biotech companies have been my biggest gainers that are cut from the same cloth as SILO!
I am urging all of our members to add SILO to the top of their watch list right now, and be ready this morning at the opening bell!
Regards,
Your PPF Team
Update: Global WholeHealth Partners, Corp (GWHP: OTC) Describes the Pros and Cons of the Common Types of COVID-19 Test Kits Available
https://finance.yahoo.com/news/global-wholehealth-partners-corp-gwhp-145000079.html
New Update #1 New Blockbuster Biotech Stock Silo Pharma (SILO) Set to EXPLODE
As Wall Street & Silicon Valley Invest Heavy Into This Space!
Dear Fellow Trader,
What if you could buy shares of Pfizer when it was a tiny, little-known company?
If you bought and held this biotech stock, even if all you bought is a few thousand bucks, you would be a multi-millionaire right now.
I’ve identified the next early-stage biopharmaceutical stock that could potentially ride the next biotech breakout wave.
Immediately turn your attention to Silo Pharma Inc. (SILO)
Silo Pharma Inc. is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research to innovatively address underserved conditions including Fibromyalgia, PTSD, Parkinson’s, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.
Wall Street & Silicon Valley Leaders Are Rushing
to Support Psychedelic Medicine
As psilocybin boldly merges into modern pharmacopeia, the emerging field of psychedelic medicine continues forward amidst this electrifying renaissance. Pioneers such as MAPS, Usona Institute and Compass Pathways have been awarded the coveted “breakthrough status” for their psilocybin-based therapies by the US Food & Drug Administration. This designation marked a historic moment for the overall psychedelic revolution and has caught the attention of various notable investors from Wall Street and Silicon Valley.
Peter Thiel, the notable billionaire backer of Compass Pathways, is the co-founder of PayPal and one of Facebook’s first major investors. He is also the chairman of aforementioned Palantir Technologies, which posted its best week since it went public in September, adding about $17 billion in market value as a broad rally in tech stocks helped fuel gains in the software maker.
Currently, Palantir is one of the tech industry’s most valuable private companies with a whopping valuation of $20 billion dollars. Thiel’s combined investments in Palantir and Compass Pathways highlights the significant shift in attention towards psychedelics from big players in Wall Street and Silicon Valley.
Looking at Thiel’s track record along with the significant attention towards psychedelics from big players in Wall Street and Silicon Valley, "Thiel may be onto something by investing in the psilocybin sector."
Introducing... SILO!
Now Turn Your Complete Attention to SILO
Wednesday's Focus Stock...
For investors of Silo Pharma, Inc. (SILO), a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, and general supporters of the psilocybin and ‘magic mushroom’ market, the passage of a ballot measure in Oregon just a few weeks ago to allow licensed providers to administer the hallucinogenic substance found in magic mushrooms is a significant development. As some may recall, Oregon was the first state to decriminalize the possession of small amounts of cannabis, and among the first to authorize its use for medical purposes.
Pioneering Oregon then proved a safe and regulated commercial market for cannabis and state after state continues to follow. It is worth noting that Washington D.C. passed a similar measure for mushroom based psychedelics.
And what is also of interest is that as these seminal legislative changes occur, Silo Pharma seeks to develop its own standing in the markets, having recently announced its transition from the OTC Pink Market to the OTCQB® Venture Market.
It’s a significant move through the transparency required of OTCQB companies, being quoted on a more senior quotation medium, and introducing the Company to a possible greater pool of retail investors and institutions.
Legalized psilocybin is in its infancy, and Silo Pharma appears to be in a nascent phase of its business plan despite a partnership with a major university already in place. As these new markets open up in Oregon and D.C., Silo is preparing to meet the moment.
And now to add more Breakout-Fuel to this bullish pick is their latest Blockbuster Patent News!
Silo Pharma, Inc. Announces Filing of Three
U.S. Provisional Patent Applications
Each Provisional Patent Application Relates to Psilocybin
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced the filing of three distinct U.S. Provisional Patent applications with the U.S. Patent and Trademark Office ("USPTO") pertaining to the central nervous system delivery of unique anti-inflammatory therapeutics coupled with psilocybin.
“Each of these provisional patents relates to the continued research and development of the central nervous system-homing peptides covered by the UMD option agreement to deliver certain compounds,” stated Eric Weisblum, Chairman and CEO of Silo Pharma.” We are excited to have taken this important action with respect to our recently announced collaboration with UMD.”
A provisional patent application is a critical step on the road to commercial viability. As the climate for intellectual property rights becomes more and more competitive, a provisional patent application successfully establishes an early effective filing date and allows the patent applicant or a licensee to ascribe the phrase "patent pending" to any product development and methodologies associated with the patent’s subject matter.
“These patent applications, together with Silo’s efforts to bring scientific talent, resources, and industry leaders together, allows the Company to continue its development of novel therapeutics in the psychedelic category,” stated Mr. Weisblum.
SILO also has several more bullish catalysts working in its favor:
Another bullish catalyst is SILO recently appointed of Dr. Matthew Johnson of John Hopkins University as a member of the advisory board.
Dr. Matthew W. Johnson, Ph.D., a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins, is one of the world’s most published scientists on the human effects of psychedelics and has conducted seminal research in the behavioral economics of drug use, addiction and risk behavior.
Working with psychedelics since 2004, Dr. Johnson published psychedelic safety guidelines in 2008, helping to resurrect psychedelic research. He is the Principle Investigator on research showing promising data for psilocybin in treating tobacco addictions, and on funded studies investigating psilocybin in the treatment of opioid dependence and PTSD. In 2016, Dr. Johnson and colleagues published the largest study of psilocybin in treating cancer distress.
“Matt has long been recognized for his behavioral research in psychedelics and pharmacology,” added Weisblum. “His experience and talents will be invaluable as we accelerate our pursuit of market opportunities for the application of psychedelic drug therapies. We welcome Matt to our advisory board and look forward to leveraging his insights and expertise.”
Dr. Johnson was 2019 President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association and is current President of the International Society for Research on Psychedelics, an organization he founded with colleagues. He has received continuous NIH funding as Principal Investigator since 2009. He has reviewed for more than 75 journals and has served as guest editor on two special issues on psychedelics.
Dr. Johnson has reviewed grants for NIH, NSF, the US Military, and multiple governments outside of the US. He is a standing member of the Addictions Risks and Mechanisms (ARM) NIH study section. He has provided invited presentations in 13 nations.
Another bullish catalyst is SILO to Explore Unique Peptide Delivery of Psilocybin Utilizing this Novel Technology Represents Key Differentiator in Emerging Psilocybin Space.
SILO announced that it has executed an option agreement with the University of Maryland, Baltimore with respect to the exploration of the potential use of central nervous system-homing peptides in vivo and their use for the investigation and treatment of multiple sclerosis and other neuroinflammatory pathology. Silo Pharma’s intends to explore the development of unique therapeutics that utilize these CNS Homing Peptides. Silo plans on initiating studies to evaluate the potential use of this invention to deliver Psilocybin based therapeutics directly to targeted areas of a patient.
This technology refers to phage-encoded peptides identified as being unique, inflamed CNS-specific markers. These peptides zero in on the spinal cord and, to a lesser extent, the cerebellum, in a rodent model of Multiple Sclerosis (MS). These peptides are designed to address many challenges, as they are expected to be pathology-specific (damaged, inflamed tissue only), are tissue specific (CNS), and can be used as an imaging tool for inflammation of the spinal cord. As such, Silo Pharma believes that they may be used in the detection of diseased tissue and for targeting therapeutic agents to the CNS to treat MS and other neuroinflammatory diseases.
“The option agreement gives Silo access to a potential unique and vital approach which significantly differentiates us within the Psilocybin space,” stated Eric Weisblum Chairman and CEO of Silo Pharma. “The ability to deliver psilocybin and other psychedelic compounds directly to targeted areas of the body with this technology could be significant by increasing the efficacy of the treatment while reducing the amount of medicine needed. There is a tremendous need for creative and unique therapeutics for patients suffering from rare diseases. We believe this novel approach coupled with our planned research of psilocybin as a therapeutic presents an exciting opportunity for the company.”
As you can see, there are multiple bullish catalysts signaling breakout gain potential!
It’s important to remember that historically, small-cap biotech, biopharmaceutical,
life sciences, nutraceutical and therapeutics companies have been my biggest gainers that are cut from the same cloth as SILO!
I am urging all of our members to add SILO to the top of their watch list right now, and be ready Wednesday morning at the opening bell!
?SamuraiStocks
Trading Research Team
This came in the other day. They are looking correct today. COVID-19 Vaccine Sends Stock Soaring 1,000% — Huge Potential
Ahead With Global WholeHealth Partners (GWHP)!
Here we go, GWHP is breaking out to the upside very fast this morning.
If you haven't taken a look at this stock yet, this is your chance. Make sure you have GWHP pulled up on your trading screen.
Technical Analysis
#1.) The previous close was $1.10/share
#2.) The 1st Resistance Point Was - $1.16
#3.) The 2nd Level Resistance Point Was - $1.22
#4.) The 14 Day RSI at 80% - $3.24
The Next Technical Breakout Point Represents 165% Upside.
For anyone that may have missed my email from earlier, I've included a copy below.
The Street is Taking Notice of this Emerging Player in
the Hyper-Growth Covid-19 Diagnostics Space!
There’s finally some good news about the global pandemic.
On Monday, shares of "Pfizer Inc. (NYSE: PFE)" Sky-rocketed up in price on the coat-tails of Covid-19 Vaccine.
Turn your full attention to another COVID-19 stock set to surge in price practically overnight according to several Wall Street analysts.
This little-known $1.25/share COVID-19 medical diagnostics company manufactures & distributes rapid antigen test kits for our country.
The U.S Navy base in California was one of the very first buyers of their serologic rapid blood test that detects the virus in under 15 minutes flat.
I know for a FACT you’re looking for the biggest gains, small companies positioned to disrupt massive industries have the greatest potential to skyrocket.
A stock like this has the potential to turn a $10,000 investment into $166,000 in just one year?
So be sure you read the research reports below, to see why two analysts predict a staggering price target on GWHP....10X gains in as little as 12 months.
Immediately turn your attention to Global WholeHealth Partners (GWHP)
This is our next breakout stock ready to move in a major way, here's why...
If you had bought 25,000 shares of my previous Covid-19 diagnostics stock Co-Diagnostics when I had first initiated coverage on it at $.85/share and sold it at its high of $30.99/share, you'd be sitting on approx. $750,000 right now.
My track record for Covid-19 related stock trades has dished out 3,545% gains with my previous Covid-19 diagnostics alert which ran from $.85 to $30.99 following a favorable response to its EUA earlier this year, reaching a peak valuation of 20x next years EPS.
Using A Similar Multiple On GWHP, Investment Research Analyst
Projects GWHP Could Reach $11.20 – Which is 1,000% Upside Potential!
Using a similar multiple on my newest Covid-19 diagnostics stock GWHP, Investment Research Analyst Rob Goldman at Goldman Small Cap Research projects GWHP could reach $11.20.
If you missed my previous Covid-19 related profile run from $.85 to $30, here is your second chance with my newest Covid-19 diagnostics stock GWHP.
The Street is Taking Notice of this Emerging Player in
the Hyper-Growth Covid-19 Diagnostics space!
Headlines about the "global health crisis" continue to dominate as the "second wave" of Covid-19 Hits the country.
With no signs of the 'virus' slowing down yet, the demand for Rapid Diagnostic Test (“RDT”) and Real Time Polymerase Chain Reaction Test (“RT-PCR”) has been Skyrocketing!
And that brings me to Mondays alert GWHP, which could easily dish out some of the BIGGEST GAINS of 2020, with its 1,000% in upside potential!
It's important to note Global WholeHealth Partners has a history of experiencing increased upside potential, and has presented investors with considerable upside multiple times and may be positioned for a new round of gains.
Analyst are bullish on GWHP, following their Blockbuster News!
You must take this particular pick very serious, pay close attention to the magnitude of their latest Blockbuster News, GWHP now offers the New “FDA” Cleared Fingerstick for Rapid Covid-19 Test, get results in minutes (with the "Only FDA Authorized") Covid-19 POC serology Test.
GWHP Bullish Catalysts – Multiple Breakout Catalysts
Signaling Breakout Gain Potential
CATALYST #1 Potential Breakout Catalyst – Breaking Global WholeHealth Partners (GWHP) Now Offers the New “FDA” Cleared Fingerstick for Rapid Covid-19 Test, Results in Minutes (with the "Only FDA Authorized") Covid-19 POC serology Test.
With several bullish catalysts working in GWHP favor, I believe that the next big breakout could be potentially about to take place.
....GWHP has been the subject of a number of investment research analyst reports!
GWHP Bullish Catalysts – Multiple Analyst Ratings
Signaling Breakout Gain Potential
CATALYST #2 Potential Breakout Catalyst – Breaking Investment Research Analyst Rob Goldman at Goldman Small Cap Research issued analyst coverage on Global WholeHealth Partners (GWHP), issuing a $11.20/share Price Target, Representing an approx. 1,000% Upside Potential.
In the Investment Research report below, analyst Rob Goldman discusses the major sales for Covid-19 test kits and the potential impact on the Company and its valuation.
Image
Taglich Brothers Initiates Coverage of Global WholeHealth Partners (GWHP)
Investment Research Analyst Howard Halpren Issued Speculative Buy!
CATALYST #3 Potential Breakout Catalyst – Breaking Taglich Brothers Initiates Coverage of Global WholeHealth Partners and Investment Research Analyst Howard Halpren Issued Speculative Buy.
In the Investment Research Report Below, Taglich Brothers Analyst Howard Halpren Issued Speculative BUY, analyst Howard Halpern discusses Global WholeHealth Partners penetrating rapid COVID-19 diagnostic testing market given that it has three COVID-19 diagnostic tests submitted and pending for FDA emergency use approval.
Image
Huge Breakthrough For GWHP Receives "FDA" Acknowledgement
Letter for Its "Antigen Rapid Test" For COVID-19!
CATALYST #4 Potential Breakout Catalyst – Huge Breakthrough For GWHP Receives "FDA" Acknowledgement Letter for Its "Antigen Rapid Test" For Covid-19!
The Antigen test is a"Game Changer" because the test reveals if a person is "currently" infected with a pathogen such as the SARS-CoV-2 virus. Once the infection has gone, the antigen disappears.
GWHP Rapid Diagnostic Testing (RDT) Whole Blood, Serum /Plasma Can Detect Between 15 -20 Minutes, Which Predict Diseases Ahead Of Its Industry Competitors.
My Track Record for Covid-19 related stock trades has dished out 3,545% gains with my previous Covid-19 Diagnostics stock — Co-Diagnostics (CODX) is a company that I had previously covered from my initial alert on July 2, 2019 at $.85/share all the way to its 52 week high of $30.99/share on Aug 3rd, following a favorable response to its EUA earlier this year, reaching a peak valuation of 20x next years EPS... providing my "loyal members with 3,545% Gains."
Using A Similar Multiple On GWHP, Investment Research Analyst
Projects GWHP Could Reach $11.20 – Which is 1,000% Upside Potential!
Follow Me Closely Here, if you missed my previous profile run from $.85 to $30.99 booking a staggering 3,545% gains, here is your second chance with my newest Covid-19 diagnostics stock Global WholeHealth Partners (GWHP).
If their $11.20 price target is indicative of what's to come, we could see potential gains of up to 1,000% according to Investment Research Analyst Rob Goldman at Goldman Small Cap Research!
If you haven't taken a look at this stock yet, this is your chance. Make sure you have GWHP pulled up on your trading screen...It could be headed towards a potential $11.20/share, according to analysts.
“The Company’s goal is to offer the fastest and most reliable in-vitro diagnostic tests on the market, while keeping ahead in R&D, by offering FDA Approved Troponin I Whole Blood, Nasal Swab Influenza A & B, and Throat Swab Strep A, Urine and Saliva Drug Testing, Whole Blood Mononucleosis, H. Pylori, FOB, and several other tests.”
Global WholeHealth Partners Corporation (GWHP)
The Next Major Covid-19 Diagnostics Breakout Company!
GWHP is set to emerge as a major provider of COVID-19 rapid diagnostics test kits, disrupting the "BOOMING" $5.1 Billion COVID-19 Diagnostics Market... which could be the best way to potentially play one of the year’s hottest sectors.
At this point we have very high expectations for this revolutionary company, seeing its backed by multiple analysts’ one of which strongly believes it could potentially reach $11.20!
>>> Six Key Investment Highlights That Could Potentially Send
Shares Soaring, Combined With its 1,000% Upside <<<
Goldman Small Cap Research Analyst Issued $11.20/share Price Target.
Taglich Brothers Analyst Howard Halpren Issued Speculative BUY.
Founded in 1991, Taglich Brothers, Inc. is a full-service brokerage firm specializing in the microcap segment of the market for publicly traded securities.
In studies performed earlier this year, GWHP’s diagnostic antibody test produced such an enviable accuracy rate that the Department of the Navy placed an order for 1000 kits. The test’s accuracy was found to be over 97%, with limited false positives, a major differentiator.
If you missed the CODX run from $3 to $30, here is your second chance to research GWHP.
GWHP is set to emerge as a key provider of COVID-19 diagnostics test kits, an estimated $5.1BIL market. The Company has filed two Emergency Use Applications (EUAs) with the FDA—one for an anti-body test and the other for a rapid global antigen test, with responses pending.
>>> Five Competitive Advantages <<<
GWHP clearly has advantages as compared to other manufactures in the space. Its proprietary COVID-19 test kit pending EUA approval boasts high sensitivity and specificity results that ensure lower false positives than many approved kits in use today.
GWHP rapid blood test kit can detect antibodies in 15 minutes---one of the fastest times which can aid in overall testing throughout the country.
GWHP is one of the few manufactures that has submitted multiple applications to the FDA for diagnostic testing.
GWHP recently submitted a new EUA with the FDA for a Global Antigen CoViD19 SARS2 Rapid Test---which follows its prior antibody diagnostic test EUA.
If both tests are approved, GWHP could have the potential to emerge as a high-profile diagnostic testing company with one of the most diverse, rapid point-of-care (PoC) Covid-19 test portfolios in the market.
Here Are A Few Reasons Why Savvy Traders
Are About to Pounce On GWHP?
Imagine what it would be like? … going into the holiday season with another Multi-Bagger under your belt… imagine if you could increase your wealth by 10X TIMES!
Early investors typically grow their wealth—perhaps 10 times or more, when they're early. There really is no time to waste if you want to get positioned on the right side of the train, right?
Savvy investors succeed for a reason… they do their DD, and they get in early…
All this leads to one conclusion: people who pull up GWHP at this initial stage could be setting themselves up potentially for a major gain as the company becomes a significant player!
Because for all the reasons I’ve outlined, I am urging all of my members to add GWHP to the top of their watch list right now, and be ready Monday morning at the opening bell!
Your final step is to complete your research on GWHP before this weeks breakout.
I am urging all of my members to add GWHP to the top of their watch list right now, and be ready Monday morning at the opening bell!
Sincerely,
Editor In Chief, OTCtipReporter Team
She is moving on up. Global WholeHealth Partners Corporation (GWHP)
The Next Major Covid-19 Diagnostics Breakout Stock!
Dear Fellow Trader,
Immediately turn your attention to Global WholeHealth Partners (GWHP)
If you haven't yet read GWHP full profile, do so HERE
So far, GWHP is breaking out to the upside very fast, building strong momentum, closing yesterday up 30% at a high of the day at $1.43.
With several bullish catalysts working in GWHP favor, I believe that the next big breakout could be potentially about to take place.
If you haven't taken a look at this stock yet, this is your chance. Make sure you have GWHP pulled up on your trading screen.
Click here to get the full Report!
Yours for greater profits,
Editor In Chief, SamuraiStocks
News out Global WholeHealth Partners, Corp Describes the Pros and Cons of the Common Types of COVID-19 Test Kits Available
Global WholeHealth Partners Corp.
Tue, November 17, 2020, 6:00 AM EST
San Clemente, CA, Nov. 17, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- The coronavirus disease 2019 (COVID-19) pandemic has placed the world in a tailspin, which the healthcare industry has responded to in kind with the development and rapid deployment of tests designed to detect infection. Many of these tests help clinicians and researchers accurately identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19.
And while these tests have been crucial in identifying and tracking cases of infection and disease-related morbidity and mortality, they aren’t without their potential drawbacks.
https://finance.yahoo.com/news/global-wholehealth-partners-corp-describes-110000210.html
Time to make a switch. Findit FDIT allows members to post content and still share it to FACEBOOK FB.
Findit App Submitted into Google Play Store for Internal and External Final Testing
https://finance.yahoo.com/news/findit-app-submitted-google-play-165000961.html
Findit is building new things out. With so many people frustrated with Twitter and Facebook looks like Findit traffic is picking up. Check out the Alexa Ranking and the new app version is about to go live.
Findit App Submitted into Google Play Store for Internal and External Final Testing
https://www.otcmarkets.com/stock/FDIT/news/Findit-App-Submitted-into-Google-Play-Store-for-Internal-and-External-Final-Testing?id=280130
Its about to get REAL Findit App Submitted into Apple IOS TestFlight for Final Testing
If you have an IOS Apple Phone you can literally download the App in TestFlight posts go live to the App and Findit.com.
With all the hoopla after the or during the election people are looking to a new place to post instead of Facebook or Twitter. Any shareholders that post to any social sites and are not posting on Findit HOW COME ? LOL Post on Findit and help yourself and you shares. The more members posting the more traffic this could spiral upwards with new members posting each and every day.
https://finance.yahoo.com/news/findit-app-submitted-apple-ios-142500212.html
[URGENT!] Explosive Catalyst (NWPN) Poised to Explode as 5 New States
Legalize $2.5 Billion-Plus Cannabis Markets!
Dear Fellow Trader,
The rapidly growing cannabis space has provided some of the most exciting investments, and investors are trying to get their hands on the next explosive stock!
...Estimates from Forbes Magazine show that it could be a $22BIL market!
The Wall Street Journal explains that CBD is everywhere and calls it “The #1 industry you need to be paying attention to.”...over 50 Million Americans use CBD products, Gallup Poll says.
This Booming Industry Is Expected To Grow
By 3,623% In The Next Five Years!
My research has uncovered a very promising bio-pharmaceutical company with explosive growth looking to bridge the worlds of science and cannabis.
The Company desires to have an FDA approved medicine that focuses on nausea and other ailments....with FDA approval, it will be available for pharmacies to dispense, and will be on the approved list to be covered and paid for by ins-carriers.
Immediately turn your attention to The Now Corporation (NWPN)
This is my next cannabis stock ready to move in a major way, here’s why…
Big Political Wins For Marijuana - 5 New States
Legalized $2.5 Billion-Plus Cannabis Markets!
Pot stocks are set for a big rally and Mondays alert has a history of epic overnight moves...tuesday's election was a landslide win for marijuana, 5 new states legalized $2.5 billion-plus cannabis markets...a big catalyst that could potentially send shares soaring!
According to cannabis market firm New Frontier Data, Marijuana legalization in the additional U.S. states is estimated to grow the industry’s size by $9 billion!
Another catalyst that could potentially send shares soaring is respected Technical Analysis site, Barchart issued NWPN a 100% BUY long term rating.
Voters in NJ, Arizona, Three Other States Legalize
Potential $2.5 Billion-Plus Cannabis Markets!
Voters approved new markets in Arizona, Mississippi, Montana, New Jersey and South Dakota that could generate more than $2.5BIL in medical and recreational cannabis sales a year by 2024.
New Jersey, Arizona, Montana and South Dakota represented the 12th, 13th 14th and 15th states in the country to leg—al—ize recreational marijuana markets, according to media projections.
Voters also approved new medical markets in Mississippi and South Dakota, capping a 100% w-i-n in rate for state leg—ali—za—tion ballot measures in the 2020 election.
Big Political Wins For Marijuana!
Tuesday was politically successful for marijuana advocates, which means election day was a plus for cannabis investors as well. Ballot initiatives in Arizona, Montana, New Jersey, and South Dakota that sought to legalize recreational marijuana use by adults all passed on November 3.
Marijuana equities have been rallying in recent weeks and their rise should continue into next year. Now's the time to get aboard the "green rush." The following chart tells the story of pot's multi-year growth:
?It's only a matter of time before marijuana prohibition is removed not just by the states, but also by the federal government. Several bills are currently pending in Congress that would lift federal restrictions on pot.
Federal and state lawmakers increasingly embrace marijuana legalization, which in turn creates an enormous multi-year tailwind for the cannabis sector. With Congress set to resume action on marijuana legislation in 2021, marijuana investments are poised for a prolonged bull run.
I'm Issuing An Explosive New Breakout Bounce Play, with 194% in Upside Potential This Stock Could Quickly Double or Triple on Monday!
Huge Breakout Bounce Setup For NWPN
Just like our recent big gainer, our latest trade idea has a razor thin float and triple-digit gain potential.
In fact, the first time I brought this company to your attention was on Oct 12, when it exploded to a high of $.0145/share running up 57% from my alert at the open… It went on to hit a high of $.0175 on Nov 2, providing 90% gains from my alert on Oct 12.
I've been waiting patiently for the perfect timing for NWPN, and it appears the time could be now at its current level.
The Company is once again sitting on a bottomed-out chart, and could see the bounce of a lifetime!
The stock consolidated and closed at a very healthy price of $.009 Friday which allows for traders who potentially missed a great entry price to now jump in, but it also provides the another setup for traders who recently scored massive gains to Do It All Over Again!
On Oct 26, NWPN was trading at a low of $.0063 and it went on to breakout to a high of $.0175 on Nov 2, providing traders with 177% gains!
If the stock rises back to last Monday's high that represents Gains of 94% and if the stock reaches its 52-Week High of $.025 then that is an Even Bigger Profit of 177%!
NWPN appears to be both undervalued and oversold at these levels.
....There is no time to waste on this one!
One little spark from a catalyst could be all it takes to send it back to its previous highs of $.025/share, which would show traders 194% GAINS, from its current price of approx. $.0085!
This past spring the stock was trading as low as $.0026, which means at last month's high of $.0225, the stock was up a whopping 765%!
Not a bad return for just a few months...
It should be noted that NWPN hit $.0225 in October and the day before the stock was as low as $.0125. This means overnight the stock blew up 79%!
It should be noted that NWPN was trading at a low of $.0063 on October 26, and it exploded to a high of $.0175 on November 2. That’s a 177% gain in roughly 4 trading days!
NWPN also saw enormous gains in September moving from as low as $.0056 on 9/1 to as high as $.025 on 9/15. This was a gain of 346% in just about two weeks!
There have been many occasions where the stock has seen such tremendous upside movements and look at the stock's current chart!
The Company has several bullish catalysts on the horizon, and is on the verge of disrupting a $20BIL Cannabis Market, and has been making major strides with Blockbuster Acquisitions and Joint Ventures in the last few months!
NWPN Bringing Scientific Grade CBD To The Masses
The Now Corporation is a bio-pharmaceutical research company with a mission to improve the health and wellness of patients worldwide by building a dynamic, innovative and forward-looking research, development, education, and testing company serving the fast-growing cannabis industry across the US and Canada with Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC).
The company is dedicated to advancing the study of the medicinal use of CBD and other cannabinoid molecules and seeks to develop cannabis-derived therapeutic products backed by strict and ethical scientific research.
This includes, but is not limited to, food, paper, and textiles derived from Hemp.
NWPN has the ability to grow and analyze hemp seed genetic variability, the source of CBD, and its relationship to potency, which will aid the pursuit of effective dosing that will be required for maximal health benefits.
The company also provides Credible Scientific Research Data to the heavily regulated medical and recreational marijuana industries - currently one of the fastest growing industries in North America.
The Now Corporation Short Term Goal
NWPN has created agreements with top research scientists from major Universities and have utilized their existing labs to perform expensive research using cannabinoid compounds which are in cannabis plants.
From the research, the company will be able to publish research white papers that will contain credible data from these research laboratories.
As a result, the information that the company publishes will start to establish increased credibility in the industry, and will allow the company's products to be prescribed by physicians since they will be able to access the information in their databases.
These studies will answer many questions and stop false data and rumors about CBD/THC derived from cannabis, and the effects on the human body.
The Now Corporation Long Term Goal
NWPN desires to have an FDA approved medicine that focuses on nausea and other ailments...with FDA approval, it will be available for pharmacies to dispense, and will be on the approved list to be covered by carriers and paid for.
Ultimately, NWPN will pursue patenting the compound on a molecular level, similar to Pfizer's patent on the drug, Viagra.
How The Now Corporation Stands out Above the Rest!
NWPN will have a scientifically tested product while existing products that are available on the market may not be safe.
For example, what is the safe dosing for CBD in the human body? What is the effectiveness rate when humans consume CBD, and how much can a human take before it becomes toxic to the body?
The Federal government, along with State governments must find out this answer before deeming it safe. The company's research does not start at the plant, they will also research air, soil, and water, from a seed genetic level up to a mature plant.
NWPN Inking Blockbuster Deals!
If you couldn’t tell, NWPN is not a company to simply rest on its laurels! Let's analyze some of the company's most recent deals...
Joint Venture With Hollywood Diagnostics Center
NWPN has signed a joint venture with Hollywood Diagnostics Center to perform neurological studies using state-of-the-art imaging technology to measure brain activity by detecting changes associated with blood flow when CBD compounds are introduced to the human body.
Hollywood Diagnostics Center is a leader in the medical diagnostics field while performing over 30,000 diagnostic procedures annually!
The goal of the imaging data analysis is to detect correlations between brain activation in subjects when either non-tasked or tasked activities are performed during the scan with CBD compounds present.
It also aims to discover correlations with cognitive states after CBD compounds are introduced to the subject.
Partnership In The CBD Beverage Space
On Sept 2nd, NWPN announced they are now the Largest Shareholder in Transglobal Assets Inc. with 26.8% ownership!
...Transglobal is renowned for its Monster Elixer CBD drink.
The company is extremely interested in Transglobal Assets' Monster Elixir subsidiary both as an investment and for additional synergies.
Monster Elixir Inc. will provide customers with a wide range of high-quality CBD products from its organically grown Indoor and Outdoor gardens.
Current products include:
Pur Root Lemonade: by utilizing the natural medicines in Marijuana Roots. Its Pur Root Lemonade will come in many flavors such as Ginger Bite and Pineapple Agave, sold in bulk or retail.
Infused Olive Oils: for all of your edible baking needs, it has Olive Oils Infused with CBDs, also sold in bulk or retail.
Distillates by the cartridges: Indica, Sativa and hybrids will be available.
NWPN and Transglobal will offer a unique arrangement of CBD Edibles, from hard candies and gummies to pound cakes and pies made from scratch.
So Why Is This Such A Blockbuster Deal?
The CBD drinks market in the U.S. will be worth $260MIL by the year 2022, while the combined value of CBD and THC-infused beverages will reach $1.4BIL by 2024!
These fine CBD products will be sold at local Dispensaries and other retail outlets, including at Monster Elixir stores in the near future.
Hemp Biofuel Pilot Program
Back in January, NWPN announced a pilot program for producing derivatives from Industrial Hemp for biodiesel fuel in North Dakota.
Industrial hemp is perfectly capable of fueling the modern world without displacing food or adding to the Greenhouse effect. After almost 150 years of drilling and fracking, fossil fuel experts believe oil production could be nearing its peak and the hunt is on for a viable replacement such as hemp derived biofuel.
The NOW Biodiesel Pilot Program forms part of the existing joint venture agreement for the cultivation of Industrial Hemp to be grown near Grand Forks, North Dakota. For the 2020 grow season, the pilot program will consist of 400 acres and, upon a successful growing season, the following years will then expand to include over 1000+ acres.
Hemp Biofuel is looking like an attractive alternative to crude oil and NWPN could soon get recognized for its pilot program by producing derivatives from Industrial Hemp for biodiesel fuel in North Dakota!
NWPN may truly be the most ambitious and competitive CBD/Cannabis Stock we've ever come across.
From Scientific-grade CBD approved by the FDA and incorporating Diagnostics to CBD products like Beverages and Oils and even Hemp-based Biofuel - this company has its hands in all facets of the industry.
The company is even looking to create an organic CBD nausea drug for SpaceX and NASA to provide astronauts on extended missions - and eventually to Mars!
.....NWPN is "Out of this World" with unlimited upside?
But it's not out of reach.... especially as it trades at its current levels!
With all this and more, it's no wonder why multiple Analysts are behind them!
The Barchart Technical Opinion Rating Issued
NWPN Bullish 100% BUY Opinion
Wall Streets leading provider of market data to the global financial, media, and commodity industries just issued NWPN a bullish 100% BUY Rating Long Term.
Now if that doesn't excite you, maybe the fact that NWPN chart looks to be on the verge of a Full-on BREAKOUT, signaling a bullish BOUNCE!
So, what's the bounce potential this time? A bounce back to just October highs of $.0225 would deliver up to 194%+ Gains - but a bounce to Septembers highs would generate traders an IMMEDIATE 200% GAINS!
Multiple Breakout Catalysts Signaling
Breakout Gain Potential
It’s important to note, NWPN is no stranger to breakouts. For example, it was trading at a low of $.0091 on Sep 29th, it surged to a high of $.0225 on Oct 2nd for 147% in gains, VIRTUALLY overnight:
On Sep 3rd, it was trading at $.0056, it surged to a high of $.0250 on Sep 15th for 346% gains.
I've been waiting patiently for the perfect timing for NWPN, and it appears the time could be now at its current level.
I am urging all of our members to add NWPN to the top of your watch list right now, and be ready Monday morning at the opening bell!
?Sincerely,
Editor In Chief, OTCtipReprter
Could be a nice bounce coming. Look at Level 2 how thin it truly is.
Between 0.118 up to 0.21 only seeing 48,200 shares
ASCM 0.118 5,000 3:24:22 PM
ETRF 0.119 5,000 3:23:24 PM
NITE 0.119 5,000 3:23:45 PM
PUMA 0.1235 5,000 2:58:04 PM
CFGN 0.13 7,200 2:57:54 PM
NTFN 0.133 5,000 2:27:57 PM
CDEL 0.159 12,000 2:59:46 PM
CSTI 0.16 9,000 2:40:47 PM
GTSM 0.1804 5,000 Nov 5, 2020
SPLN 0.21 2,500 Oct 29, 2020
VERT 0.29 2,500 Oct 29, 2020
Global WholeHealth Partners Corp. (GWHP) Announces It Now Offers the New FDA Cleared Fingerstick for Rapid COVID-19 Test Results in Minutes
https://finance.yahoo.com/news/global-wholehealth-partners-corp-gwhp-120000327.html
https://news.findit.com/news/1812777/global-wholehealth-partners-corp
GWHP Bullish Catalysts - Multiple Positive Analyst Ratings
That Could Potentially Send Shares Soaring!
Dear Fellow Trader,
Immediately turn your attention to Global WholeHealth Partners (GWHP)
This is our next "pandemic" related stock ready to move in a major way, here's why...
The street is taking notice of this emerging player in the hyper-growth Diagnostics & Research space!
Headlines about the global health crisis continue to dominate as the "second wave" of COVID-19 hits the country.
Half of US states are reporting an uptick in new COVID-19 cases!
With no signs of the virus slowing down yet, the demand for health defense products has been skyrocketing!
And that brings me to my new alert which could easily dish out some of the BIGGEST GAINS of 2020 with its 1,019% in upside potential!
Taglich Brothers Initiates Coverage of Global WholeHealth Partners (GWHP)
Taglich Brothers is a full-service broker dealer focused exclusively on microcap companies. The Company defines the microcap segment of the equity market as companies with less than $250MIL in market capitalization.
Taglich Brothers currently offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community.
The firm has selected this unique niche for two reasons.
First and foremost, the small cap market has historically outperformed the large cap market over the past 75 years.
Second, this area of the market is virtually ignored by the larger institutions and other Wall Street firms because they cannot invest enough capital in each situation to justify the expense of investigating these companies.
Their focus and high energy level allow them to exploit these inefficiencies, giving us the added advantage needed to prosper in the microcap market.
Additionally, Investment Research Analyst Rob Goldman at Goldman Small Cap Research issued analyst coverage on Global WholeHealth Partners, issuing a $11.20/share price target!(Representing an approx. 1,019% upside potential)
In the Investment Research report below, analyst Rob Goldman discusses the major sales opportunity for COVID-19 test kits and the potential impact on the Company and its valuation.
>>> Six Key Investment Highlights That Could Potentially Send
Shares Soaring, Combined With its 1,019% Upside <<<
Goldman Small Cap Research Analyst Issued $11.20/share Price Target.
Taglich Brothers Analyst Howard Halpren Issued Speculative BUY.
Founded in 1991, Taglich Brothers, Inc. is a full-service brokerage firm specializing in the microcap segment of the market for publicly traded securities.
In studies performed earlier this year, GWHP’s diagnostic antibody test produced such an enviable accuracy rate that the Department of the Navy placed an order for 1000 kits. The test’s accuracy was found to be over 97%, with limited false positives, a major differentiator.
If you missed the CODX run from $3 to $30, here is your second chance to research GWHP.
GWHP is set to emerge as a key provider of COVID-19 diagnostics test kits, an estimated $5.1BIL market. The Company has filed two Emergency Use Applications (EUAs) with the FDA—one for an anti-body test and the other for a rapid global antigen test, with responses pending.
>>> Five Competitive Advantages <<<
GWHP clearly has advantages as compared to other manufactures in the space. Its proprietary COVID-19 test kit pending EUA approval boasts high sensitivity and specificity results that ensure lower false positives than many approved kits in use today.
GWHP rapid blood test kit can detect antibodies in 15 minutes---one of the fastest times which can aid in overall testing throughout the country.
GWHP is one of the few manufactures that has submitted multiple applications to the FDA for diagnostic testing.
GWHP recently submitted a new EUA with the FDA for a Global Antigen CoViD19 SARS2 Rapid Test---which follows its prior antibody diagnostic test EUA.
If both tests are approved, GWHP could have the potential to emerge as a high-profile diagnostic testing company with one of the most diverse, rapid point-of-care (PoC) Covid-19 test portfolios in the market.
Once again, if you missed my previous covid-19 diagnostics stock run from $.85 to $30.99 which booked a whopping 3,545% gains, here is your second chance with my newest pick GWHP.
The Bottom Line...
If you haven't taken a look at GWHP yet, this is your chance. Put GWHP on your screen.
My Track Record for COVID-19 Related Stock Trade Ideas has dished out 3,545% GAINS with my previous "Pandemic" related stock Co-Diagnostics which is a company that I had previously covered from my initial alert July 2, 2019 at $.85/share all the way to its recent high of $30.99/share on Aug 3rd following a favorable response to its EUA earlier this year, reaching a peak valuation of 20x next year's EPS... providing my loyal members with 3,545% GAINS.
Using A Similar Multiple On GWHP, Investment Research Analyst
Projects GWHP Could Reach $11.20 Which Is 1,019% Upside!
Follow Me Closely Here, if you missed my previous stock pick run from $.85 to $30.99 booking a staggering 3,545% gains, here is your second chance with my newest COVID-19 diagnostics stock GWHP.
You must take this particular pick very seriously, pay attention to the magnitude of their Bombshell "FDA" Acknowledgement Letter for Its "Antigen Rapid Test" For Covid-19.
I am urging all of my members to add GWHP to the top of their watch list right now, and be ready Wednesday morning at the opening bell!
MarketCaliber
Trading Research Team
Findit Features Members NutraCap Labs, American Craftsman Renovations and Carolina Pool Consultants
https://finance.yahoo.com/news/findit-features-members-nutracap-labs-162000421.html
Global WholeHealth Partners Corp. (GWHP): The Commentary for Submitting the (EUA) Application # PEUA201789 Date 09/14/2020: for the Global Antigen CoViD19 SARS2 Rapid Test as Mentioned in the 8K Filing on 09/15/20
https://finance.yahoo.com/news/global-wholehealth-partners-corp-gwhp-124800955.html
Findit Enters Final Testing Stage of its App That Does Not Censor Users Prior to Roll Out in Apple App Store and Google Play Store
https://finance.yahoo.com/news/findit-enters-final-testing-stage-110000913.html
Goldman Small Cap Research Issues Research Update on Findit, Inc.
https://finance.yahoo.com/news/goldman-small-cap-research-issues-200000200.html
Findit, Inc. FDIT Investor Deck. Great Video on how Findit is being used by businesses and individuals to increase their online presence.
https://www.otcmarkets.com/stock/FDIT/news/FDIT-Investor-Deck?v&id=4229
Barchart Technical Opinion STRONG BUY The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.
Long term indicators fully support a continuation of the trend.
Mondays Pick BRZL Could Be The Biggest Pandemic Related
Breakout Stock With 1,900% in Upside Potential!
Dear Fellow Trader,
?I just uncovered our next "Pandemic" related stock trade idea poised to surge in price as the "second wave" COVID-19 hits the country.
Immediately turn your attention to Scepter Holdings Inc. (BRZL)
This is our next "Pandemic" related stock ready to move in a major way, here's why...
The street is taking notice of this emerging player in the hyper-growth consumer defensive packaged goods space!
Headlines about the global health crisis continue to dominate as the "second wave" of COVID-19 hits the country.
Half of US states are reporting an uptick in new Covid-19 cases!
With no signs of the virus slowing down yet, the demand for health defense products has been skyrocketing!
And that brings me to my new alert which could easily dish out some of the BIGGEST GAINS of 2020 and deliver potential gains of up to 1,900%!
BRZL Focused On The Booming Hand Sanitizer
Market Exploding Up Over 1,400%!
As we continue to through the health crisis, hand sanitizer may be one of the best tools for defense, as well as washing our hands and wearing masks.
Whether people agree on wearing masks or not, we can certainly agree that keeping our hands clean is a great way to keep bacteria and viral particles off of them.
Morgan Stanley has not long ago warned its clients that a "sustained resurgence in coronavirus infections should emerge this autumn in tandem with the arrival of flu season and bring with it more targeted lockdowns across the nation."
Analyst Matthew Harrison wrote that his best case scenario projects a "second wave" in the fall with new causes summing between 40,000 and 50,000 nationwide!
The virus is hands down the biggest topic of 2020 and while it has impacted many aspects of life negatively, Wall Street has seen some positive.
"Pandemic" related stocks have seen big gains. Consumer brands related stocks have seen explosive growth in the new "stay at home" economy where people are stockpiling and ordering products from their couches.
My track record for covid-19 related stock trades has dished out 3,545% gains with my previous "Pandemic" related stock Co-Diagnostics which is a company that I had previously covered from July 2nd 2019 at $.85 cents all the way to its recent high of $30.99/share on Aug 3rd providing members with 3,545% gains.
Another one of my previous "Pandemic" related stocks was Axsome Therapeutics which I alerted premarket at $5.00 on Jan 7, 2019 and it rocketed to a high of $109.94/share on Dec 30, 2019 providing members with 2,098% gains.
Another one of my previous "Pandemic" related stocks was Applied DNA Sciences which I alerted premarket AT $4.80 on April 15, and it rocketed to a high of $16.39/share on May 14th providing members with 241% gains.
Another one of my previous "Pandemic" related stocks was Sorrento Therapeutics which I alerted premarket at $4.30 on May 15th and it rocketed to a high of $19.39/share on Aug 10th providing members with 350% gains.
If you missed the runs on any of my previous "Pandemic" related stocks, here is your second chance with BRZL!
The fact that we may be experience a change in behavior for years to come after COVID-19 in order to continue protecting ourselves from viruses, makes companies that focus on defense products very attractive.
There is a company trading under the radar that has several exciting products that they are involved with and some of these products can be used as a defense against the deadly outbreak!
BRZL may soon catch tremendous attention with brands that could become household names including a novel hand sanitizer!
Scepter Holdings offers premier quality, proven products that the company says will perform above and beyond as advertised. The company manages the sales and brand development of high-performance consumer packaged goods and seeks to acquire performing brands to add to the company’s portfolio of products and brands sold online and through strategic retail relationships.
The company leverages its expertise to bring to market functional products developed with an eye towards sustainability and performance. From makeup that heals and brings oxygen to your skin, to daily vitamin sprayables that can enhance your health.
The company is involved in the market and distribution of two brands: Gevitta Vitamin Spray and Dermacia
Recently the company also announced the development of a new hemp infused hand sanitizer formula and has signed an exclusive sales and marketing agreement with Dr. Robert Brunst to market his innovative NoseBudz® nasal air filter.
BRZL Focused On The Booming Hand Sanitizer
Market Exploding Up Over 1,400%!
The global hand sanitizer market has been redefined thanks to the coronavirus.
This year has market has seen gains in the hundreds of percents compared to last year and the global Hand Sanitizer market is expected to reach a staggering $17.2BIL by the year 2026, according to a new report by market Study Report.
According to a report by Adobe Analytics, the demand for hand sanitizer in U.S. spiked to 1,400%!
Walmart India also reported an unprecedented spike in hand cleaning product sales, compelling the chain to put limits on purchase. The pandemic is, therefore, likely to surge revenues for companies in this market, as long as the crisis persists.
"Hand sanitizer is going to be very difficult to have 100 percent on stock on for some time," said Walmart CEO Doug McMillon this year "We're still replenishing it and shipping it, but as soon as it hits the stores, it's going."
The coronavirus has hit over 14MIL cases around the world. Just three weeks ago this number was around 10MIL. This pandemic has made it very clear that it is important to protect ourselves from germs and viruses. One way to do this is by washing our hands or using hand sanitizer when we can't wash our hands.
Considering the current domestic need for disinfectant and cleaning supplies, BRZL is responding by pursuing a new hand sanitizer formula that will disinfect while supporting healthy skin.
The new formula will contain hemp oil extract, rich in omega fatty acids.
The goal is to provide a hand sanitizer product that is less harsh on the skin when used multiple times a day. The frequent use of sanitizer can dry out hands and make them feel chapped.
"Scepter has been fortunate to have good relationships with manufacturing partners that enable us to quickly develop new products in response to consumer needs. We anticipate a positive response to our new hemp infused hand sanitizer formula once it has been launched," stated Adam Nicosia, Vice President of Sales for Scepter Holdings.
A report published by Fior Markets has revealed that the demand for hand sanitizers has increased by an astonishing 1,400%!
The report also states that the global hand sanitizer market is expected to grow from $1.2BIL in 2019 to $2.14BIL by 2027, at a CARG of 7.5% during the forecast period 2019-2027.
The pressing need for hand sanitizer could also continue to go on even after this pandemic eases which means a substantial market for years to come for BRZL!
BRZL Company Makes Hand Sanitizer Donation!
The company recently donated hand sanitizer to Technical Air Balance in Phoenix, Arizona., which provides air filtration and balancing services to schools, universities, many hospitals and medical facilities, plus the Border Patrol in the Greater Phoenix area and across Arizona.
During the pandemic, their team has engaged in providing necessary assistance to many facilities that have continued operating during the crisis or are upgrading during the pandemic to reopen with better filtration and ventilation.
Access to liquid and gel hand sanitizer in bulk has been very difficult for small companies.
Rachel A. Murdock, the owner of Technical Air Balance responded, "In this troubled time in our country, we needed help and Scepter offered that help which gives our staff and technicians confidence to continue to serve the needs of our community and state."
BRZL has been researching hand sanitizer production and sales, and as a result, was able to secure a supply of liquid and gel hand sanitizer for donation to Technical Air Balance.
Chairman of the Board, Mr. Robert Van Boerum has said, "We are grateful to be able to support a small business that is making a difference behind the scenes during this difficult time."
BRZL Launches on Amazon with Vitamin D Supplement
?That May Boost Immunity!
Scepter Holdings has introduced Gevitta branded vitamin sprays, Glow and Multi, recently for sale on Amazon.
Gevitta Glow vitamin spray is a liquid Vitamin D spray supplement. Customers looking for a simple to dispense Vitamin D supplement will appreciate the taste and convenience of Gevitta Glow.
Gevitta Multi vitamin spray is a multivitamin supplement spray containing a blend of Vitamins C, D, E, Thiamine, Niacin, B6, Folic Acid, B12, Biotin, and Pantothenic Acid. Gevitta Multi contains many of the essential vitamins found in competitive multivitamin tablets, but in a more convenient spray form.
The best thing to build our immunity to fight coronavirus are vitamins, and Vitamin D is associated with increased autoimmunity as well as an increased susceptibility to infection!
Pills often degrade in a person’s Gastro-Intestinal tract, while Gevitta Vitamin Sprays’ super fine spray delivery system offers the consumer a more convenient and pleasant approach to daily supplementation.
"We are happy to introduce Gevitta Multi and Glow for purchase through our store and Amazon. Our Gevitta vitamin sprays are a great solution for customers searching for a convenient vitamin supplement.", stated Adam Nicosia, Vice President of Sales for Scepter Holdings.
BRZL Penetrating the Growing Nose Filter Market!
BRZL has signed an exclusive sales and marketing agreement with Dr. Robert Brunst to market his innovative NoseBudz® nasal air filter.
NoseBudz is a simple, innovative, nasal air filter designed to stop aerosolized viral particles and allergens. The unique patent-pending conical filters in NoseBudz are designed to filter particles one-micron or larger, while maintaining sufficient airflow to allow normal breathing through the nose.
Scepter Holdings will take the responsibility for marketing and selling NoseBudz through brand owned websites and Amazon. Dr. Robert Brunst and his team will provide product inventory and funding to directly support marketing expenses. Sales revenue less cost of goods, expenses, returns, merchant fees, etc., will be shared with Scepter in exchange for its marketing and sales services.
"We believe the market for NoseBudz nasal air filter is stronger than it has ever been. We look forward to relaunching the brand under Scepter's guidance.", stated Adam Nicosia, Vice President of Sales.
A nose filter or nasal filter is an air filter designed to fit inside the human nostrils to prevent the nasal inhalation of allergens, pollutants, and irritants. It has even been said to sometimes prevent viruses too!
According to a Market Study Report study, over the next five years the Nasal Filter market will register a 5.8% CAGR in terms of revenue, the global market size will reach $8MIL by 2024, from $6MIL in 2019!
In February the company said sales were up over 400% compared to the same period last year!
BRZL Also Has Two Other Products In
Two Booming Markets!
BRZL is involved with two brands in two very different industries that could become household names - Gevitta Vitamin Spray and Dermacia.?
It was in August of 2019 that BRZL announced that Gevitta Vitamin Sprays are available for purchase on Amazon and Gevitta.com.
Since completing an asset purchase agreement with Gevitta last year, the company had been actively engaged in preparing Gevitta Vitamin Sprays for launch on the e-commerce platform.
Amazon is the biggest retailer in the world now, overtaking Walmart last year. Its platform has billions of shoppers each month.
The company has secured the rights to numerous proprietary spray formulas, and has launched three of the best selling formulas for sale. Gevitta Awake is marketed to consumers looking for a convenient alternative to energy shots and drinks. Gevitta Burn is an easy to use alternative to supplements supporting weight loss. Gevitta Dream is a simple to use, travel friendly, melatonin supplement designed to support sleep.
“Gevitta branded sprays add a unique product offering to Scepter’s portfolio of performance products, we are excited develop and grow the brand.”, stated Robert Van Boerum Chairman of the Board.
The company's sprays are a superior method for taking vitamins and supplements instead of pills or capsules.
There has been a tremendous amount written about increasing the value to consumers that take vitamin and mineral supplements. There is enormous research evidence showing that supplements can help protect people against diseases like heart disease and cancer.
Gevitta recently completed the development of Fisetin infused supplement spray formulations to be marketed by BRZL along with existing Gevitta branded supplement sprays on Gevitta.com and Amazon.
?Fisetin, a plant polyphenol present in many fruits and vegetables, such as strawberries and apples, and has shown anti-cancer activity in lab studies. In other studies, Fisetin also appears to help regulate inflammatory pathways and deactivates several major inflammatory compounds.
After closing an asset purchase agreement with EcoScientific Labs in 2019, BRZL turned its attention to reinvigorating the Dermacia brand and launching Dermacia Pro cosmetics for sale on Amazon.
It was in the fall of last year that BRZL announced the launch of DermaciaPro.com, which focuses exclusively on selling Dermacia Pro cosmetics.
Dermacia is already being talked about by celebrities and has been featured in some of the biggest magazines in the world such as Glamour, Vogue, Cosmopolitan, Allure, Health, Redbooks, and Ladies Home Journal!
?Dermacia brand products in 2020 are up over 400% compared to the same period last year and the company has experienced the majority of sales growth through Amazon.
After closing an asset purchase agreement with EcoScientific Labs in 2019, BRZL turned its attention to reinvigorating the Dermacia brand and launching Dermacia Pro cosmetics for sale on Amazon.
It was in the fall of last year that BRZL announced the launch of DermaciaPro.com, which focuses exclusively on selling Dermacia Pro cosmetics.
Dermacia is already being talked about by celebrities and has been featured in some of the biggest magazines in the world such as Glamour, Vogue, Cosmopolitan, Allure, Health, Redbooks, and Ladies Home Journal!
?Dermacia brand products in 2020 are up over 400% compared to the same period last year and the company has experienced the majority of sales growth through Amazon.
BRZL Sales Are Climbing Fast!
Last November BRZL posted quarterly financial results for the quarter ended September 30, 2019 and revealed that product sales more than doubled those of the previous quarter!
The company has spent the last few quarters proving its sales and marketing plan. Recent sales data indicates that the model is working and sales of existing product lines continue to increase month over month.
According to a recent article on Forbes.com, retail brands are enjoying higher returns with Amazon Advertising than with Facebook or Google. The article cited data from a recent Feedvisor study which concluded that 66% of consumers begin their new product search on Amazon, that Amazon drives a 7X return for most brands.
BRZL invests most of its advertising dollars in Amazon Advertising, and has recent leveraged some of the new advertising features introduced by Amazon in the last 6 months to increase return on advertising spend (ROAS).
January and February of 2020 have demonstrated a rise in ROAS over last year, as well as an increase in sales over the same period last year, which supports additional investment in Amazon Advertising.
BRZL Impressive Comparables!
BRZL is trading among some very impressive comparables to demonstrate how massive the skin care and supplement arenas are.
Last year Estée Lauder's shares rallied 55%! The company's stock hit new records driven by robust demand for its high-end skin-care products. Estee Lauder Companies Inc. (NYSE: EL) is trading over $150 a share!
Supplement stocks in the market like Nu Skin Enterprises, Inc. (NYSE: NUS) and Herbalife Nutrition Ltd. (NYSE: HLF) are also good examples of the growth potential in the sector for BRZL. NUS is over $30 a share while HLF is over $40!
BRZL The Massive Hemp Derived CBD Breakout Play!
Since the passage of the 2019 Farm Bill, BRZL has launched an initiative to review the potential added value of CBD, sourced from industrial hemp, infused into Dermacia Pro cosmetic formulas.
Consumer demand for CBD infused products continues to increase, and as the market and interest for CBD infused skin care products grows, the company intends to keep Dermacia Pro cosmetics competitive.
Nielsen Predicts That, By 2025, The U.S. Hemp-Derived CBD
?Market Could Be A $6BIL Industry!
“Thanks to the passage of the 2019 Farm Bill, we are confident that the appropriate regulatory path for products infused with CBD sourced from industrial hemp will soon become clear.”, stated Mr. Van Boerum.
The company supports the latest pending California legislation that would hemp-derived CBD for use as an ingredient in food, beverages and cosmetics.
California bill AB-228 would modify state regulation around the use of CBD as an ingredient in food, beverages, and cosmetics. Current regulation prohibits the use of hemp-derived CBD in said products.
Scepter supports the coalition of hemp farmers, advocates and local governments that have worked to prepare AB-228, which would reverse a 2018 stipulation from California's health department that hemp-derived CBD cannot be added to food.
Hemp has historically been treated as an agricultural product and Scepter encourages California lawmakers to restore that same status, providing support to California farmers.
"There is significant consumer demand for CBD infused products, and we look forward to regulatory changes that would make it legal for California companies to produce hemp-derived CBD infused consumables," stated Adam Nicosia, Vice President of Sales.
The upcoming presidential election in November could be a catalyst to bring new states into the fold of legislation. New York, New Jersey, and Connecticut could all vote to marijuana and this would be huge for BRZL market! It would expand their product offering and distribution.
BRZL The Formation of an Advisory Board
with Industry Experts!
BRZL recently announced the formation of an Advisory Board and appointed industry experts Thomas Johannesen, Jordan Erskine and Gavin Collier.
Thomas Johannesen brings nearly 30 years of enterprise and ecommerce technology expertise to the Board. Mr. Johannesen has developed e-commerce solutions with various public and private companies.
Scepter looks forward to Mr. Johannesen's guidance and advice as the company continues to enhance their ecommerce strategy.
Jordan Erskine, President and Co-Founder of Dynamic Blending, has 18+ years in the manufacturing industry. Dynamic Blending specializes in the turnkey manufacturing of skin care, hair care, personal care, cosmetics and more.
Gavin Collier, CEO & Co-Founder of Dynamic Blending, brings 10+ years of experience manufacturing consumables on top of his successful legal career. Scepter looks forward to working closely with Jordan and Gavin through Dynamic Blending to develop additional products and line extensions.
"We are excited to form our Advisory Board and look forward to working closely with each board member as we continue to innovate at Scepter Holdings," stated Robert Van Boerum, Chairman of the Board.
Chad Murdock Was Also Recently
Added To The Board!
He is the President of M2G Media and is an executive producer, producer/director, market and writer with over 35 years of creative, marketing and management experience. Chad continues to be one of the most creative innovators in Direct Response.
Murdock has worked on joint projects with companies and products such as SC Johnson, Estee Lauder, Your Baby Can Read, Epson, Time Life Music & Video, Hooked on Phonics, Body Flex, Home Shopping Network, QVC, Select Brands, Braun, Bell South, Fitness Quest, Tony Little Enterprises, Nissan, Hoover & Warner Vision.
He Has Been A Producer/Direct/exec-Producer On Shows
That Have Grossed Over $2BIL In Revenue!
Mr. Van Boerum has said, "We are excited to have Chad as part of our Advisory Board. Chad's deep knowledge of the industry will be critical in the development of new brands and the execution of their promotional campaigns."
BRZL has another bullish catalyst working in its favor!
Another Bullish Catalyst Is BRZL Shares Have
Exploded Many Times!...
BRZL has seen tremendous breakouts many times this year and quickly too!
It was on July 13th that share prices jumped from $0.01 to $0.0196 the next day for a gain of nearly 100%.
On June 26th share prices were as low as $0.0091 and on June 27th were as high as $0.0245 for a move of over 160%.
In May share prices moved from $0.012 to $0.0455 for a gain of nearly 280% which occurred in only a few days.
On 3/2 share prices were as low as $0.0295 and on 3/3 they were as high as $0.147!! Gains of nearly 400% overnight!
The stock also ran from $0.0071 on February 14th to as high as $0.029 on February 26th for a gain of 308% in ten days!
This is nothing compared to what happened in February... the stock was at sub-penny levels and by the beginning of March was at nearly 15 cents for a breakout of almost 2,000%!
Yes, quadruple digit gains accumulated in just weeks...
With a high of almost 15 cents, there could be Epic Bounce Potential that could deliver Massive Triple-Digit Gains thanks to the stock's 1,900% Upside!
BRZL shares, in the past, have seen momentous gains of nearly 2,000% in only weeks!
With the coronavirus pandemic having no end in sight any time soon, the company could gain major recognition for the defense products it is involved with.
Sales of products have been jumping this year and 2020 could be one of the biggest years of sales!
Jumping into the hand sanitizer space and nose filter market could get the company recognized for its efforts in the fight against coronavirus.
Plus, with an expert in the sales arena recently added to the board, things are looking even more promising!
Share prices hit nearly 15 cents not long ago and they were at sub-penny prices earlier this year. Could history be ready to repeat itself?
With an undeniable upside of 1,900%, a massive bounce could be gearing up for BRZL so put the stock on your radar!
I am urging all of our members to add BRZL to the top of your watch list right now, and be ready Monday morning at the opening bell!
?Hototc
Trading Research Team
Barchart Technical Opinion STRONG BUY
The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.
Long term indicators fully support a continuation of the trend.
https://www.barchart.com/stocks/quotes/FDIT/overview
Here are the facts from FDIT Press Release today SOURCE: FINDIT
https://finance.yahoo.com/news/findit-inc-shows-posts-feeds-124000641.html
Findit, Inc. Shows All Posts in Feeds; Findit Does Not Censor Your Posts
ATLANTA, GA / ACCESSWIRE / October 16, 2020 / Findit, Inc., a Nevada Corporation (OTC PINK:FDIT) owner of Findit.com, a full-service social networking management platform and online marketing service, provides freedom of speech and does not censor member posts. In addition to Findit providing a social networking platform that allows its members to share differences of opinion without censorship (the first amendment) Findit does not have algorithms that place certain posts in front of your while not showing you other posts.
Findit, which calls their posts "Right Nows", which would be similar to what Twitter calls a Tweet, shows each Right Now in chronological order. Friends and Followers of members will see each and every one of their friends' posts in the time and date order they were posted.
Peter Tosto of Findit, Inc. stated, "While other social networking sites are being called out for censorship, removing posts, placing members accounts on hold from posting at all, Findit is welcoming the views and diversity of individuals to be posted and shared on Findit."
Findit is an open platform to all of its members - each member can see another members posts regardless of whether they follow the member or not. Anyone who visits Findit or downloads the Findit App can also see all the content posted without having to join or follow someone. In addition to members and non-members having access to the posts made by Findit members, search engine also have complete access so they can and do crawl Findit members' profiles, posts, pictures and about section and also indexing those pages in their search results.
Clark St. Amant of Findit stated "We really provide a breath of fresh air when it comes to transparency for our members. By having all of their content visible to everyone including search engines that includes but is not limited to Google, Yahoo and Bing, along with the share feature offered on Findit from each post, Findit empowers members to cast a wider net and share to up to eighty other social networking sites."
Findit offers all of its members the same platform and the same exposure regardless of the number of friends or followers you have - everyone is offered the same tools and no one is censored.
Disclaimer: Findit does not allow pornographic or terroristic content to be posted.
About Findit, Inc.
Findit.com which is a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing and other search engines access to its content posted to Findit so it can be indexed in these search engines as well. Findit provides Members the ability to post, share and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status Updates posted in Findit can be crawled by outside search engines which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites by members and non-members. Findit provides Real Estate Agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account. Findit, Inc., is focused on the development of monetized Internet-based web products that can provide an increase in brand awareness of our members. Findit, Inc., trades under the stock symbol FDIT on the OTC Pinksheets.
Safe Harbor:
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Findit, Inc. to differ materially from those implied or expressed.
CONTACT:
Clark St. Amant
404-443-3224
SOURCE: Findit, Inc.
https://finance.yahoo.com/news/findit-inc-shows-posts-feeds-124000641.html
Findit, Inc. Shows All Posts in Feeds; Findit Does Not Censor Your Posts
ACCESSWIRE ACCESSWIRE•October 16, 2020
ATLANTA, GA / ACCESSWIRE / October 16, 2020 / Findit, Inc., a Nevada Corporation (OTC PINK:FDIT) owner of Findit.com, a full-service social networking management platform and online marketing service, provides freedom of speech and does not censor member posts. In addition to Findit providing a social networking platform that allows its members to share differences of opinion without censorship (the first amendment) Findit does not have algorithms that place certain posts in front of your while not showing you other posts.
Findit, which calls their posts "Right Nows", which would be similar to what Twitter calls a Tweet, shows each Right Now in chronological order. Friends and Followers of members will see each and every one of their friends' posts in the time and date order they were posted.
Peter Tosto of Findit, Inc. stated, "While other social networking sites are being called out for censorship, removing posts, placing members accounts on hold from posting at all, Findit is welcoming the views and diversity of individuals to be posted and shared on Findit."
Findit is an open platform to all of its members - each member can see another members posts regardless of whether they follow the member or not. Anyone who visits Findit or downloads the Findit App can also see all the content posted without having to join or follow someone. In addition to members and non-members having access to the posts made by Findit members, search engine also have complete access so they can and do crawl Findit members' profiles, posts, pictures and about section and also indexing those pages in their search results.
Clark St. Amant of Findit stated "We really provide a breath of fresh air when it comes to transparency for our members. By having all of their content visible to everyone including search engines that includes but is not limited to Google, Yahoo and Bing, along with the share feature offered on Findit from each post, Findit empowers members to cast a wider net and share to up to eighty other social networking sites."
Findit offers all of its members the same platform and the same exposure regardless of the number of friends or followers you have - everyone is offered the same tools and no one is censored.
Disclaimer: Findit does not allow pornographic or terroristic content to be posted.
About Findit, Inc.
Findit.com which is a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing and other search engines access to its content posted to Findit so it can be indexed in these search engines as well. Findit provides Members the ability to post, share and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status Updates posted in Findit can be crawled by outside search engines which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites by members and non-members. Findit provides Real Estate Agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account. Findit, Inc., is focused on the development of monetized Internet-based web products that can provide an increase in brand awareness of our members. Findit, Inc., trades under the stock symbol FDIT on the OTC Pinksheets.
Safe Harbor:
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Findit, Inc. to differ materially from those implied or expressed.
CONTACT:
Clark St. Amant
404-443-3224
SOURCE: Findit, Inc.
View source version on accesswire.com:
https://www.accesswire.com/610788/Findit-Inc-Shows-All-Posts-in-Feeds-Findit-Does-Not-Censor-Your-Posts
Findit, Inc. Shows All Posts in Feeds; Findit Does Not Censor Your Posts
ATLANTA, GA / ACCESSWIRE / October 16, 2020 / Findit, Inc., a Nevada Corporation (OTC PINK:FDIT) owner of Findit.com, a full-service social networking management platform and online marketing service, provides freedom of speech and does not censor member posts. In addition to Findit providing a social networking platform that allows its members to share differences of opinion without censorship (the first amendment) Findit does not have algorithms that place certain posts in front of your while not showing you other posts.
Findit, which calls their posts "Right Nows", which would be similar to what Twitter calls a Tweet, shows each Right Now in chronological order. Friends and Followers of members will see each and every one of their friends' posts in the time and date order they were posted.
Peter Tosto of Findit, Inc. stated, "While other social networking sites are being called out for censorship, removing posts, placing members accounts on hold from posting at all, Findit is welcoming the views and diversity of individuals to be posted and shared on Findit."
Findit is an open platform to all of its members - each member can see another members posts regardless of whether they follow the member or not. Anyone who visits Findit or downloads the Findit App can also see all the content posted without having to join or follow someone. In addition to members and non-members having access to the posts made by Findit members, search engine also have complete access so they can and do crawl Findit members' profiles, posts, pictures and about section and also indexing those pages in their search results.
Clark St. Amant of Findit stated "We really provide a breath of fresh air when it comes to transparency for our members. By having all of their content visible to everyone including search engines that includes but is not limited to Google, Yahoo and Bing, along with the share feature offered on Findit from each post, Findit empowers members to cast a wider net and share to up to eighty other social networking sites."
Findit offers all of its members the same platform and the same exposure regardless of the number of friends or followers you have - everyone is offered the same tools and no one is censored.
Disclaimer: Findit does not allow pornographic or terroristic content to be posted.
About Findit, Inc.
Findit.com which is a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing and other search engines access to its content posted to Findit so it can be indexed in these search engines as well. Findit provides Members the ability to post, share and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status Updates posted in Findit can be crawled by outside search engines which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites by members and non-members. Findit provides Real Estate Agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account. Findit, Inc., is focused on the development of monetized Internet-based web products that can provide an increase in brand awareness of our members. Findit, Inc., trades under the stock symbol FDIT on the OTC Pinksheets.
Safe Harbor:
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Findit, Inc. to differ materially from those implied or expressed.
CONTACT:
Clark St. Amant
404-443-3224
SOURCE: Findit, Inc.
View source version on accesswire.com:
https://www.accesswire.com/610788/Findit-Inc-Shows-All-Posts-in-Feeds-Findit-Does-Not-Censor-Your-Posts
News release on Findit FDIT From Yahoo Finance on Company Findit, Inc. Shows All Posts in Feeds; Findit Does Not Censor Your Posts
https://finance.yahoo.com/news/findit-inc-shows-posts-feeds-124000641.html
Fri, October 16, 2020, 8:40 AM EDT·4 mins read
ATLANTA, GA / ACCESSWIRE / October 16, 2020 / Findit, Inc., a Nevada Corporation (OTC PINK:FDIT) owner of Findit.com, a full-service social networking management platform and online marketing service, provides freedom of speech and does not censor member posts. In addition to Findit providing a social networking platform that allows its members to share differences of opinion without censorship (the first amendment) Findit does not have algorithms that place certain posts in front of your while not showing you other posts.
Findit, Inc. Shows All Posts in Feeds; Findit Does Not Censor Your Posts
https://finance.yahoo.com/news/findit-inc-shows-posts-feeds-124000641.html
The volume since June 5th on FDIT picked up quite a bit. Take the volume over 11 trading days from June 5th to June 20th the total volume was approx. 9 million plus shares. Compare that for the previous 12 months from June 4th 2019 to June 4th 2020 to total volume was approx. 13 million shares. Only 4 million shares more over a 50 week period versus 2 weeks.
In filings by the company Firth has not sold any shares in years. In fact a vast majority of the holdings by Firth and insiders has been voluntarily converted from preferred to common a few years back and remains locked up.
I have reviewed the IR firm that was recently hired and looked at their track record this year.
Here are a few over the past 6 months.
CODX was trading under a $1.00 at the end of 2019. It closed on Friday at $17.24 on 3,177,040 shares. When coverage began from the same firm as WAFU and the FDIT took on recently the shares were at around $1.13. Coverage began and volume went from 91,100 shares one day to 36,063,100 shares the next. The stock did not move much the first day which was odd. Or maybe not maybe the traders got caught off guard and traded it while sellers came in with the new found volume but as time went on and not much time the stock traded up from $1.13 on Jan. 9th to $15.96 close on Feb 27th. And like I wrote earlier closed at $17.24 yesterday.
WAFU So this one covered about 2 weeks ago. June 9th was at $2.13 on 27,500 volume day of coverage traded up to $15.39 closed at $7.15 on 65,019,500 shares. These are verifiable number not an opinion. On Friday the stock closed at $6.02 up approx. 300% from 9 days earlier when the coverage began.
People using Findit to reach more people. Great picture and accomplishments by this Findit member.
http://findit.com/reganpatterson/RightNow/its-been-a-bit-since-ive-posted-a-workout/6f980bc2-50e3-4534-a102-6e2e20c53ed2?httproute=True
Level 2 FDIT Thin on the offer side. Minimum amount need to reflect on the offer is 5,000 shares above 10 cents. Out of 11 market makers 7 reflect minimum. Vert which is at .30 cents showing min of 2,500. Only 4 market makers reflecting more than minimum, combined above minimum offers totals to 53,061 shares.
NITE 0.10 5,000 Oct 12, 2020
CDEL 0.1128 17,060 10:01:07 AM
PUMA 0.1145 5,000 8:47:34 AM
OTCX 0.115 35,000 8:00:00 AM
ETRF 0.12 10,000 10:12:03 AM
CFGN 0.124 5,000 Oct 12, 2020
GTSM 0.126 11,061 9:30:10 AM
CSTI 0.13 5,000 8:30:17 AM
NTFN 0.135 5,000 Oct 8, 2020
SPLN 0.15 5,000 Oct 5, 2020
VERT 0.30 2,500 Sept 30, 2020
See short report since September 28, 2020 reflects 5,169,200 shares short
Date Close High Low Volume Short Volume % of Vol Shorted
Oct 12 NA NA NA 219,529 52,410 23.87
Oct 09 NA NA NA 210,664 65,375 31.03
Oct 08 NA NA NA 127,870 59,056 46.18
Oct 07 NA NA NA 924,135 277,016 29.98
Oct 06 NA NA NA 530,793 234,158 44.11
Oct 05 NA NA NA 945,724 236,288 24.98
Oct 02 NA NA NA 1,086,102 216,845 19.97
Oct 01 NA NA NA 2,632,032 630,635 23.96
Sep 30 NA NA NA 4,963,155 1,799,888 36.26
Sep 29 NA NA NA 1,755,845 795,355 45.30
Sep 28 NA NA NA 2,509,906 802,174 31.96
https://www.otcshortreport.com/company/FDIT
Some products Findit offers. Looked over some posts on Findit and viewed some search results pretty impressive.
Get Prime For $99, Maximize Your Online Presence Maximize Your Online Presence
http://findit.com/Prime
FDIT looking strong. Not seeing dumping. Look at the volume and where it was the past few months. Nice support building in here. Over 44 million shares traded since June. Dollar amount over $4,000,000.00 small for Facebook FB but increasing for FDIT over same time last year. Company answers the phone and talks with people about their services. Sales increase and visibility keeps increasing will help. Gotta admit so many people are annoyed with the other social media platforms taking down posts because they don't like what they say, Findit is the opposite, they support the first amendment.
Anyone see this last night. Coverage is starting up on CYAP. Email went out last night. Usually get more once this starts up. Last week I got several on FDIT. It went from .06 to .25 on high volume. It backed off but the support levels moved up from when the coverage first started.
Breakout Report: 10-06-20
Cyber Apps World: Initiation of coverage
Dear Fellow Trader,
Immediately turn your attention to Cyber Apps World Inc. (CYAP)
I'm initiating coverage on Cyber Apps World (CYAP), a company that is dedicated to acquiring and developing a worldwide ecommerce internet platform with the purchase and sale of products and services by way of mobile/computer applications worldwide. Cyber Apps World anticipates making available to subscribers, an ever-growing list of applications and programs.
Symbol: CYAP
Co Name: Cyber Apps World Inc.
Company Website: www.cyberappsworld.com
Breakout Catalyst: (+)
Sector(s): Communication Services
Industry: Internet Content & Information
Business description
Cyber Apps World Inc develops a worldwide e-commerce internet platform for the purchase and sale of products and services by way of mobile/computer applications. It allows users around the world to save money on products and services from member merchants and suppliers instantly with mobile coupons, using their desktops and/or mobile devices, including smartphones.
Bringing innovative Cyber Technology to market
Cyber Apps acquires or develops additional assets and elects to spin off SmartSaveNow as a separate company, all Cyber Apps shareholders will directly receive shares proportional to their percentage interest in the stock of Cyber Apps. This means that shareholders of CYAP would then also have shares of SmartSaveNow directly in their names. While management hopes to accomplish this in the future, there is no guarantee that such an arrangement will occur.
Cyber Apps World is a research client of Penny Pick Finders Investment Research
Regards,
Your PPF Team
OTC TIP REPORTER was one of the first to bring attention to CODX
http://www.findit.com/otctipreporter/news/1812407/otc-tip-reporter-offers-customized-campaigns-for-increasing-visibility-on
View Findit Pitch Deck here https://www.transworldnews.com/wp-content/uploads/2020/10/FINDIT-INC-FDIT-INVESTOR-DECK-2020.pdf
Findit Features Members NutraCap Labs, OTC Tip Reporter and Global WholeHealth Partners
https://finance.yahoo.com/news/findit-features-members-nutracap-labs-140000703.html
Findit Features Members NutraCap Labs, OTC Tip Reporter and Global WholeHealth Partners
https://finance.yahoo.com/news/findit-features-members-nutracap-labs-140000703.html
Findit Inc (FDIT)https://www.barchart.com/stocks/quotes/FDIT/opinion
0.1400 +0.0695 (+98.58%) 10:35 ET [OTC US]
Barchart Opinion for Mon, Sep 28th, 2020
Tutorial
Alerts
Watch
Help
Overall Average:
100% Buy
Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal.
Goldman Research Price Target: $0.37 FINDIT, INC. (OTC – FDIT)The Next Great Social Media Co
Industry: Social Media Mgmt
Price Target: $0.37
https://www.goldmanresearch.com/202009251288/Opportunity-Research/the-next-great-social-media-co.html
Goldman Small Cap Research Issues New Research Report on Findit, Inc.
Our $0.37 six-month price target reflects a discount to Findit’s peer group valuation and could ultimately be much higher. If Findit achieves its growth trajectory it could emerge as a takeover candidate.
https://finance.yahoo.com/news/goldman-small-cap-research-issues-202500322.html